CI Investments Inc’s Sage Therapeutics SAGE Stock Holding History

CI Investments Inc’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-7,794	Closed	-$674K	–	1050
2020 Q4	$674K	Buy	+7,794	New	+$574K	﹤0.01%	433

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CI Investments Inc's SAGE Position: Q1 2021 in Review

CI Investments Inc sold out of Sage Therapeutics (SAGE) in Q1 2021, closing a stake of 7,794 shares — an estimated $674K sold.

CI Investments Inc first reported a position in SAGE in Q4 2020 and held it in 1 quarter. The position peaked at $674K in Q4 2020. 262 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

CI Investments Inc reported no remaining Sage Therapeutics position as of Q1 2021 after selling out during the quarter.
CI Investments Inc sold 7,794 Sage Therapeutics shares in Q1 2021, an estimated $674K.
CI Investments Inc first reported a position in Sage Therapeutics in Q4 2020 and held it in 1 quarter.
CI Investments Inc's Sage Therapeutics position peaked at $674K in Q4 2020.
262 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on CI Investments Inc's 13F filing for Q1 2021, filed 13 May 2021.